Strategy
Viewpoint: How Progressive’s Relationship With ‘The Robinsons’ Could Be at Risk
Progressive offered a rare look inside its strategic playbook in a recent second-quarter earnings report. Describing the firm's market share in key customer segments, the report highlighted one group ...
Taking Action: How Insurers Can Lead by Example With ESG
As environmental, social and governance issues are increasingly becoming a bigger topic of discussion in the insurance industry, Thomas Troy, president and CEO of CSAA Insurance Group—a provider of ...
How to Get Through a Core Systems Transformation: Change Management Tips
The success of a core systems implementation is only as strong as an organization's ability to adapt to it—all while maintaining business as usual (BAU). Being proactive and flexible helps drive ...
Deeper Roots: How the Latino Community Is Strengthening the Cyber Insurance Workforce
The root level is the highest permission level of access to a computer system, and most cybersecurity professionals work hard to ensure criminals don't gain root access to a system. However, the word ...
Meet the New Kid on the Block: Embedded Insurance
There's a new kid on the InsurTech block, and it's seeking to make the insurance experience faster and more personalized with embedded insurance. Embedded insurance is an emerging area of the ...
Wholesale Growth Is Cycle-Proof; Dual Distribution Has Failed: AIG’s Zaffino
Just a few days before the official start of the Wholesale & Specialty Insurance Association annual meeting in September, AIG's chief executive officer gave his take on the dominance of ...
Amazon and Netflix: Role Models for Insurers? Really?
Technology is a useful servant but a dangerous master. —Christian Lous Lange It is far too easy for people, including those who should know better—such as insurance industry professionals, ...
I Registered the Term Nuclear Verdicts®. Here’s Why.
In October 2019, a Philadelphia jury delivered an $8 billion verdict against Johnson & Johnson for its improper marketing of the antipsychotic drug Risperdal as a treatment for some mental health ...